Family Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Family Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,500	Closed	-$139K	–	182
2020 Q1	$139K	Hold	19,500	–	–	0.07%	135
2019 Q4	$466K	Hold	19,500	–	–	0.16%	98
2019 Q3	$523K	Hold	19,500	–	–	0.19%	86
2019 Q2	$529K	Buy	+19,500	New	+$612K	0.21%	87
2019 Q1	–	Sell	-17,000	Closed	-$332K	–	153
2018 Q4	$332K	Hold	17,000	–	–	0.14%	93
2018 Q3	$453K	Hold	17,000	–	–	0.26%	47
2018 Q2	$642K	Buy	+17,000	New	+$650K	0.4%	42

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Family Management's PTLA Position: Q2 2020 in Review

Family Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 19,500 shares — an estimated $139K sold.

Family Management first reported a position in PTLA in Q2 2018 and held it in 7 quarters. The position peaked at $642K in Q2 2018. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Family Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Family Management sold 19,500 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $139K.
Family Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 7 quarters.
Family Management's Portola Pharmaceuticals, Inc. position peaked at $642K in Q2 2018.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Family Management's 13F filing for Q2 2020, filed 13 Aug 2020.